StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals GTN rebate accruals by Year

GTN rebate accruals — Adjustments relating to prior year product sales ($M) ($M)

Vertex Pharmaceuticals GTN rebate accruals: -$90.4M in FY2025, up 114.7% from a year earlier.

Latest, FY2025
-90.4
Period ended Dec 31, 2025
Change on a year earlier
+114.7%
-42.1 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| Adjustments related to prior year(s) sales | (90.4)”

Source: Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗

Reported in Form 10-K MD&A (Critical Accounting Policies — Gross-to-Net Rebate Rollforward).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGTN rebate accruals — Adjustments relating to prior year product sales ($M) ($M)Year on yearSource
FY2025Dec 31, 2025-90.4+114.7%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
FY2024Dec 31, 2024-42.1+547.7%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
FY2023Dec 31, 2023-6.50-37.5%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
FY2022Dec 31, 2022-10.4-62.3%Form 10-K (vrtx-20241231.htm, filed 2025-02-13) ↗
FY2021Dec 31, 2021-27.6-4,700.0%Form 10-K (vrtx-20231231.htm, filed 2024-02-15) ↗
FY2020Dec 31, 20200.60-100.6%Form 10-K (vrtx-20221231.htm, filed 2023-02-10) ↗
FY2019Dec 31, 2019-95.5+332.1%Form 10-K (vrtx-20211231.htm, filed 2022-02-09) ↗
FY2018Dec 31, 2018-22.1+148.3%Form 10-K (vrtx-20201231.htm, filed 2021-02-11) ↗
FY2017Dec 31, 2017-8.90-4,550.0%Form 10-K (a201910k-main.htm, filed 2020-02-13) ↗
FY2016Dec 31, 20160.20-101.0%Form 10-K (a201810k-main.htm, filed 2019-02-13) ↗
FY2015Dec 31, 2015-19.4-6,566.7%Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗
FY2014Dec 31, 20140.30-93.3%Form 10-K (a201610k-main.htm, filed 2017-02-23) ↗
FY2013Dec 31, 20134.50–Form 10-K (a201510k-main.htm, filed 2016-02-16) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals GTN rebate accruals ($M), annual FY2013–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/gtn-adj-prior

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.